Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

June Ye · SciRah

Researcher profile · Semantic Scholar

June Ye

Share profile

June Ye — researcher profile on SciRah

h-index: 13
Works: 26
Citations: 1,207

Most-cited papers

Once-weekly albiglutide versus once-daily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): a randomised, open-label, multicentre, non-inferiority phase 3 study.
R. Pratley, M. Nauck, A. Barnett, M. Feinglos +7 more
2014The Lancet Diabetes and Endocrinology322 citations Open access
Semantic Scholar
Immune checkpoint inhibition in sepsis: a Phase 1b randomized, placebo-controlled, single ascending dose study of anti-PD-L1 (BMS-936559)
R. Hotchkiss, E. Colston, Sachin P. Yende, D. Angus +11 more
2019Critical Care Medicine207 citations Open access
Semantic Scholar
Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab
R. Hotchkiss, E. Colston, Sachin P. Yende, E. Crouser +16 more
2019Intensive Care Medicine198 citations Open access
Semantic Scholar
HARMONY 4: randomised clinical trial comparing once-weekly albiglutide and insulin glargine in patients with type 2 diabetes inadequately controlled with metformin with or without sulfonylurea
P. Weissman, M. C. Carr, June Ye, D. Cirkel +3 more
2014Diabetologia133 citations Open access
Semantic Scholar
Cardiovascular safety of albiglutide in the Harmony programme: a meta-analysis.
M. Fisher, M. Petrie, P. Ambery, J. Donaldson +2 more
2015The Lancet Diabetes and Endocrinology75 citations
Semantic Scholar
Remogliflozin Etabonate, a Selective Inhibitor of the Sodium-Glucose Transporter 2, Improves Serum Glucose Profiles in Type 1 Diabetes
S. Mudaliar, D. Armstrong, Annie A. Mavian, R. O'Connor‐Semmes +6 more
2012Diabetes Care54 citations Open access
Semantic Scholar
Conversion to seronegative status after abatacept treatment in patients with early and poor prognostic rheumatoid arthritis is associated with better radiographic outcomes and sustained remission: post hoc analysis of the AGREE study
D. Jansen, P. Emery, J. Smolen, R. Westhovens +5 more
2018RMD Open46 citations Open access
Semantic Scholar
Body mass index and clinical response to intravenous or subcutaneous abatacept in patients with rheumatoid arthritis
M. D'Agostino, R. Alten, E. Mysler, M. le Bars +5 more
2017Clinical Rheumatology30 citations Open access
Semantic Scholar
A randomized dose-finding study demonstrating the efficacy and tolerability of albiglutide in Japanese patients with type 2 diabetes mellitus
Y. Seino, N. Inagaki, Hajime Miyahara, Inaha Okuda +6 more
2014Current Medical Research and Opinion30 citations Open access
Semantic Scholar
Effects of a Novel Nitroxyl Donor in Acute Heart Failure: The STAND-UP AHF Study.
G. Felker, J. McMurray, J. Cleland, C. O'Connor +21 more
2020JACC. Heart failure25 citations Open access
Semantic Scholar
Haemodynamic effects of the nitroxyl donor cimlanod (BMS‐986231) in chronic heart failure: a randomized trial
Ni-Nian N. Lang, Faheem Ahmad, John G. F. Cleland, Christopher M. O'Connor +19 more
2021European Journal of Heart Failure21 citations Open access
Semantic Scholar
Efficacy of Abatacept and Adalimumab in Patients with Early Rheumatoid Arthritis With Multiple Poor Prognostic Factors: Post Hoc Analysis of a Randomized Controlled Clinical Trial (AMPLE)
R. Fleischmann, M. Weinblatt, H. Ahmad, M. Maldonado +3 more
2019Rheumatology and Therapy17 citations Open access
Semantic Scholar
Pharmacokinetics and Pharmacodynamics of the SGLT2 Inhibitor Remogliflozin Etabonate in Subjects with Mild and Moderate Renal Impairment
R. O'Connor‐Semmes, S. Walker, A. Kapur, E. Hussey +6 more
2015Drug Metabolism And Disposition15 citations
Semantic Scholar
Identification of biomarkers of response to abatacept in patients with SLE using deconvolution of whole blood transcriptomic data from a phase IIb clinical trial
S. Bandyopadhyay, S. Connolly, O. Jabado, June Ye +6 more
2017Lupus Science and Medicine12 citations Open access
Semantic Scholar
Potential modification of the UKPDS risk engine and evaluation of macrovascular event rates in controlled clinical trials
Fred Yang, June Ye, Kenneth Pomerantz, M. Stewart
2013Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy8 citations Open access
Semantic Scholar
Type 2 diabetes mellitus development programs in the new regulatory environment with cardiovascular safety requirements
Fred Yang, M. Stewart, June Ye, D. DeMets
2015Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy7 citations Open access
Semantic Scholar
Determining MRI Inflammation Targets When Considering a Rheumatoid Arthritis Treat-to-Target Strategy: Results of a Randomized, Placebo-Controlled Trial
H. Ahmad, J. Baker, M. Østergaard, June Ye +2 more
2019Advances in Therapy5 citations Open access
Semantic Scholar
Baseline Objective Inflammation by Magnetic Resonance Imaging as a Predictor of Therapeutic Benefit in Early Rheumatoid Arthritis With Poor Prognosis
H. Ahmad, J. Baker, M. Østergaard, P. Emery +4 more
2020Arthritis care & research3 citations Open access
Semantic Scholar
702: THE PROGNOSTIC FACTORS OF SEVERE FEVER WITH THROMBOCYTOPENIA SYNDROME A RETROSPECTIVE STUDY
Min Yang, June Ye, Tian-Feng Hua, Yin Lu
20181 citations
Semantic Scholar
Abstract 13133: Effect of Ocedurenone in Patients With Uncontrolled Hypertension and Stage 3b/4 Chronic Kidney Disease - Subgroup Analysis of a Phase 2b Clinical Trial
June Ye, J. McCabe, V. Benn, Y. F. Yang +4 more
2022Circulation0 citations
Semantic Scholar
34513 Deucravacitinib efficacy in psoriatic arthritis by baseline DMARD use: Exploratory analysis from a phase 2 study
A. Deodhar, M. Nowak, June Ye, T. Lehman +3 more
2022Journal of American Academy of Dermatology0 citations
Semantic Scholar
HEMODYNAMIC EFFECTS OF NITROXYL DONOR BMS-986231 COMPARED TO NITROGLYCERIN OR PLACEBO IN PATIENTS WITH CHRONIC HEART FAILURE-A RANDOMIZED DOUBLE-BLIND CROSSOVER TRIAL
G. Felker, J. McMurray, J. Cleland, C. O'Connor +18 more
20200 citations Open access
Semantic Scholar
1504: IMMUNE CHECKPOINT INHIBITORS IN SEPSIS
Richard Hotchkiss, E. Colston, Sachin P. Yende, Derek C. Angus +15 more
20180 citations
Semantic Scholar
Targets Therapy Type 2 diabetes mellitus development programs in the new regulatory environment with cardiovascular safety requirements
Fred Yang, M. Stewart, June Ye, D. DeMets
20150 citations
Semantic Scholar
Targets Therapy Type 2 diabetes mellitus development programs in the new regulatory environment with cardiovascular safety requirements
Fred Yang, M. Stewart, June Ye, D. DeMets
20150 citations
Semantic Scholar
DMD062828 1077..1083
O. Robin, Connor-Semmes, Susan Walker, A. Kapur +7 more
20150 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Stewart×6
Invite
M. Stewart — researcher profile on SciRah
Fred Yang×4
Invite
Fred Yang — researcher profile on SciRah
E. Colston×3
Invite
E. Colston — researcher profile on SciRah
Sachin P. Yende×3
Invite
Sachin P. Yende — researcher profile on SciRah

×3

Invite

L. Moldawer — researcher profile on SciRah

Invite

E. Crouser — researcher profile on SciRah

Invite

G. Martin — researcher profile on SciRah

Scott C. Brakenridge×3

Invite

Scott C. Brakenridge — researcher profile on SciRah

Invite

F. Mayr — researcher profile on SciRah

Invite

P. Park — researcher profile on SciRah

Invite

I. Catlett — researcher profile on SciRah

Invite

D. Grasela — researcher profile on SciRah